Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.583
-0.026 (-4.25%)
At close: Feb 21, 2025, 4:00 PM
0.622
+0.039 (6.67%)
After-hours: Feb 21, 2025, 7:50 PM EST
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $8.43 million as of February 21, 2025. Its market cap has increased by 91.69% in one year.
Market Cap
8.43M
Enterprise Value
4.33M
1-Year Change
91.69%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $8.43M, a decrease of -87.60%. That is a compound annual growth rate of -19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.40M | -30.00% |
| Dec 31, 2024 | 12.00M | 118.18% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.22% |
| Dec 30, 2016 | 32.40M | -37.33% |
| Dec 31, 2015 | 51.70M | -23.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |